Bell Gully has authored the New Zealand chapter in a publication which looks at antitrust laws and regulations in the pharmaceutical industry across 29 jurisdictions worldwide.
This is the second year the Global Competition Review has published Getting the Deal Through - Pharmaceutical Antitrust, and the second time Bell Gully partners Phil Taylor and Torrin Crowther have contributed a chapter on pharmaceutical regulatory law in New Zealand.
They review how mergers between pharmaceutical companies are controlled, what constitutes anti-competitive conduct and how authorities manage such conduct, along with legal trends and developments in the pharmaceutical area.
Click here to read the New Zealand chapter, reproduced with permission from Law Business Research.
This article was first published in Getting the Deal Through – Pharmaceutical Antitrust 2009.
For further information please visit www.GettingTheDealThrough.com
For further information please contact:
This publication is necessarily brief and general in nature. You should seek professional advice before taking any action in relation to the matters dealt with in this publication.